• 2018

    15 L pilot scale facil­i­ty estab­lished

  • 2017

    new VLP patent grant­ed in EU

  • 2016

    col­lab­o­ra­tion with Bio­Sun on devel­op­ment of a Gar­dasil-like HPV vac­cine

  • 2015

    first col­lab­o­ra­tions in the vet­eri­nary vac­cine field

  • 2014

    SUN Glob­al FZE as strate­gic investor

  • 2013

    bio-sim­i­lar tech trans­fers to Viet­nam, Thai­land and Indone­sia

  • 2012

    first col­lab­o­ra­tions in the area VLP based vac­cines

  • 2011

    first bio-sim­i­lar tech­nol­o­gy trans­fers & estab­lish­ment of secre­to­ry E. coli plat­form

  • 2010

    acqui­si­tion of the patent fam­i­ly „VLP vac­cines“

  • 2008

    estab­lish­ment of process devel­op­ment group, sec­ond chap­er­one patent

  • 2007

    move in facil­i­ty in Lan­gen­feld (850 sqm labs and offices)

  • 2006

    first patent grant­ed (chap­er­one)

  • 2002

    foun­da­tion as con­tract R&D com­pa­ny and first license deals